Browsing publications by Emeritus Professor Barbara Durkacz

Newcastle AuthorsTitleYear
Emily Mould
Philip Berry
Dr David Jamieson
Dr Chris Hill
Niu Tan
et al.
The DNA-PK inhibitor, NU7441, sensitises cancer cells to microtubule-targeting agents and modulates vincristine efflux in multidrug resistant cells2013
Dr Jill Hunter
Dr Elaine Willmore
Dr Julie Irving
Dr Stephany Veuger
Emeritus Professor Barbara Durkacz
et al.
NF-kappa B mediates radio-sensitization by the PARP-1 inhibitor, AG-0146992012
Dr Susan Tudhope
Dr Evan Mulligan
Dr Jill Hunter
Dr Helen Marr
Emeritus Professor Barbara Durkacz
et al.
P B S-1086, a "Pan-Rel" Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells2012
Dr Sarah Johnson
Clark Crawford
Dr Evan Mulligan
Dr Jonathan Wallis
Dr Tryfonia Mainou-Fowler
et al.
Mitoxantrone in combination with an inhibitor of DNA-dependent kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia2011
Dr Stephany Veuger
Emeritus Professor Barbara Durkacz
Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-kappa B activation2011
Dr Elaine Willmore
Dr Evan Mulligan
Dr Sarah Elliott
Emeritus Professor Barbara Durkacz
ATM Mutant Chronic Lymphocytic Leukaemia Cells are Chemosensitized by Inhibition of DNA Dependent Protein Kinase2010
Dr Sarah Johnson
Dr Tryfonia Mainou-Fowler
Emeritus Professor Barbara Durkacz
Dr Elaine Willmore
Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: A potential therapy for poor risk B-cell chronic lymphocytic leukaemia2010
Dr Evan Mulligan
Arabella Baird
Dr Jonathan Wallis
Dr Stephany Veuger
Emeritus Professor Barbara Durkacz
et al.
Relationships Between Aberrant Activity of the NF-kappa B Subunits and Outcome In Chronic Lymphocytic Leukemia: The Dual Role of DNA Damage Sensor Enzymes2010
Dr Stephany Veuger
Emeritus Professor Barbara Durkacz
Ionizing radiation-induced NF-kappaB activation requires PARP-1 function to confer radioresistance2009
Dr Elaine Willmore
Dr Sarah Johnson
Dr Tryfonia Mainou-Fowler
Professor Graham Jackson
Dr Celine Cano
et al.
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia2008
12345